Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients.
about
Lung cancer cell migration is regulated via repressing growth factor PTN/RPTP β/ζ signaling by meninMidkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell typesUnlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancerSuppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin.Chicken pleiotrophin: regulation of tissue specific expression by estrogen in the oviduct and distinct expression pattern in the ovarian carcinomasPTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma.Menin represses tumorigenesis via repressing cell proliferation.Dominant negative pleiotrophin induces tetraploidy and aneuploidy in U87MG human glioblastoma cells.The receptor protein tyrosine phosphatase (RPTP)beta/zeta is expressed in different subtypes of human breast cancer.Expression of receptor protein tyrosine phosphatase ζ is a risk factor for triple negative breast cancer relapsePAX3-FKHR regulates the expression of pleiotrophin to mediate motility in alveolar rhabdomyosarcoma cells.PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin.Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis.Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach.A 16-gene expression signature to distinguish stage I from stage II lung squamous carcinoma.Molecular characterization of salivary gland malignancy using the Smgb-Tag transgenic mouse model.
P2860
Q24339039-893C05E5-A80D-42AE-B2A4-15D93FE7DB69Q28214927-CB5683CC-60E9-46F6-9895-E3BD61C2F2B2Q28744369-1632912C-594A-4601-8C0E-C29B3993549EQ33587989-35A5FA9F-9494-4AB1-AA03-5D9893B228BAQ34230001-E106A3B5-1CDA-4E1C-90DD-FDF5F145278BQ34484195-8E35ADD0-0003-4057-8441-B0F768B6A1DCQ35376284-39E06344-C11E-458D-B935-FDB42C2440C3Q35748364-E1420A3C-1C73-4CE3-965D-8EE7EEB8F691Q36156124-27501F50-E3F5-48DC-B73D-1FB8BE0A981BQ36524110-1CC529C6-2E6E-42AC-BE99-F64CD7C47522Q37384314-67A09AF6-DF1A-4206-8237-EF7617A1786AQ38315381-841D05E7-C616-4104-ADA8-94F5648B6341Q41970491-CAE19356-545C-4EBE-96A6-EB7166585432Q45117328-2B12E173-A66D-4B02-8779-42DDDB37E007Q47246743-97C10F4C-5CC0-42FF-8FA5-96FF9A75673AQ54664683-C8F14CCF-049C-430C-AF6A-D1EDDFA168E7
P2860
Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Serum levels of the angiogenic ...... stage in lung cancer patients.
@ast
Serum levels of the angiogenic ...... stage in lung cancer patients.
@en
type
label
Serum levels of the angiogenic ...... stage in lung cancer patients.
@ast
Serum levels of the angiogenic ...... stage in lung cancer patients.
@en
prefLabel
Serum levels of the angiogenic ...... stage in lung cancer patients.
@ast
Serum levels of the angiogenic ...... stage in lung cancer patients.
@en
P2093
P2860
P356
P1476
Serum levels of the angiogenic ...... stage in lung cancer patients
@en
P2093
A Neubauer
G Zugmaier
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600202
P407
P577
2002-03-01T00:00:00Z